Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tuesday, April 13, 2010 - 9:42am
tags:
obesity, Vivus, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Roche Shuns ‘Not Invented Here Syndrome’ to Boost Sales, Profit
Bloomberg
Tuesday, April 13, 2010 - 9:40am
tags:
Roche, liscensing
Abbott Told to Turn Over CEO's Emails
WSJ Online
Tuesday, April 13, 2010 - 9:39am
tags:
Depakote, Miles White, Abbott Laboratories, off-label, Pharma CEOs
Gilead starts late stage tests of 4-in-1- HIV drug
Yahoo/AP
Monday, April 12, 2010 - 6:14pm
tags:
Gilead Sciences, Quad, HIV, Abbott Laboratories
RXi Marches Ahead on RNA Development
Minyanville
Monday, April 12, 2010 - 5:12pm
tags:
RXi Pharmaceuticals, RNA, gene silencing
Cell Therapeutics' Last 80 Days?
Minyanville
Monday, April 12, 2010 - 4:58pm
tags:
Cell Therapeutics, pixantrone
Why Pfizer Should Put Thoughts of a Somaxon Acquisition to Sleep
BNET Pharma
Monday, April 12, 2010 - 4:54pm
tags:
Pfizer, Somaxon, Silenor, M&A
[video]Healthy Growth Prospects for This Pharma Pick
Yahoo/Morningstar
Monday, April 12, 2010 - 4:52pm
tags:
Novartis
FDA approves Mylan's drug applications
Bizjournals.com
Monday, April 12, 2010 - 12:12pm
tags:
FDA, Mylan, antihypertensives, generics, Merck, Wellbutrin, GSK, Hyzaar
Stop the Presses: Hapless Biotech Genzyme May Actually Be Doing Something Right
BNET Pharma
Monday, April 12, 2010 - 12:09pm
tags:
Genzyme, Carl Icahn
Hospira offers competing bid to buy Javelin Pharma
Yahoo/AP
Monday, April 12, 2010 - 12:02pm
tags:
Hospira, Javelin, M&A, Myriad
Pharmaceutical Sales Healthcare Reform Survival Guide
Pharmareform
Monday, April 12, 2010 - 11:41am
tags:
healthcare reform
Inhibitex will continue with shingles study
Yahoo/AP
Monday, April 12, 2010 - 11:39am
tags:
Inhibitex, shingles
Vernalis CEO insists he's hunting for new drug deals
Fierce Biotech
Monday, April 12, 2010 - 10:49am
tags:
Vernalis, M&A
Javelin rockets, Myriad gains on merger termination
Marketwatch
Monday, April 12, 2010 - 10:47am
tags:
Javelin, Myriad, Hospira
Yes+Yes=No? Forest's Daxas and the Pull of Comparative Studies
InVivo
Monday, April 12, 2010 - 9:46am
tags:
comparative effectiveness, Forest Labs, Daxas, FDA
AngioDynamics: Warming Up or Cooling Off?
Motley Fool
Monday, April 12, 2010 - 9:45am
tags:
AngioDynamics
Novartis Sex-Discrimination Case: The Horrible Downside of Tolerating "Bad Apples"
BNET Pharma
Monday, April 12, 2010 - 9:44am
tags:
Novartis, discrimination
Paper: Roche, Novartis threaten to leave UK
Fierce Pharma
Monday, April 12, 2010 - 9:42am
tags:
UK, Roche, Novartis
Celgene Paints a Bright Future in Its R&D Update
Seeking Alpha
Monday, April 12, 2010 - 9:41am
tags:
Celgene, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.